• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和恶性造血过程中的微小RNA

miRNAs in Normal and Malignant Hematopoiesis.

作者信息

Kotaki Ryutaro, Koyama-Nasu Ryo, Yamakawa Natsuko, Kotani Ai

机构信息

Department of Hematology and Oncology, Tokai University School of Medicine, Hiratsuka 259-1193, Japan.

出版信息

Int J Mol Sci. 2017 Jul 11;18(7):1495. doi: 10.3390/ijms18071495.

DOI:10.3390/ijms18071495
PMID:28696359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5535985/
Abstract

Lineage specification is primarily regulated at the transcriptional level and lineage-specific transcription factors determine cell fates. MicroRNAs (miRNAs) are 18-24 nucleotide-long non-coding RNAs that post-transcriptionally decrease the translation of target mRNAs and are essential for many cellular functions. miRNAs also regulate lineage specification during hematopoiesis. This review highlights the roles of miRNAs in B-cell development and malignancies, and discusses how miRNA expression profiles correlate with disease prognoses and phenotypes. We also discuss the potential for miRNAs as therapeutic targets and diagnostic tools for B-cell malignancies.

摘要

谱系特化主要在转录水平受到调控,谱系特异性转录因子决定细胞命运。微小RNA(miRNA)是长度为18 - 24个核苷酸的非编码RNA,它们在转录后水平降低靶mRNA的翻译,并且对许多细胞功能至关重要。miRNA在造血过程中也调节谱系特化。本综述重点介绍了miRNA在B细胞发育和恶性肿瘤中的作用,并讨论了miRNA表达谱如何与疾病预后和表型相关。我们还讨论了miRNA作为B细胞恶性肿瘤治疗靶点和诊断工具的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5535985/9d9b85297c21/ijms-18-01495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5535985/9d9b85297c21/ijms-18-01495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ff2/5535985/9d9b85297c21/ijms-18-01495-g001.jpg

相似文献

1
miRNAs in Normal and Malignant Hematopoiesis.正常和恶性造血过程中的微小RNA
Int J Mol Sci. 2017 Jul 11;18(7):1495. doi: 10.3390/ijms18071495.
2
microRNAs: Key Players in Hematopoiesis.微小RNA:造血过程中的关键参与者。
Adv Exp Med Biol. 2015;887:171-211. doi: 10.1007/978-3-319-22380-3_10.
3
MicroRNAs as regulators of mammalian hematopoiesis.微小RNA作为哺乳动物造血作用的调节因子
Semin Immunol. 2005 Apr;17(2):155-65. doi: 10.1016/j.smim.2005.01.001.
4
MicroRNAs and hematopoietic differentiation.微小RNA与造血分化
Cold Spring Harb Symp Quant Biol. 2006;71:205-10. doi: 10.1101/sqb.2006.71.014.
5
Regulation of the MIR155 host gene in physiological and pathological processes.miR-155 宿主基因在生理和病理过程中的调控。
Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14.
6
A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.微小RNA的宏观视野:微小RNA的发现及其在造血作用和血液学疾病中的作用
Int Rev Cell Mol Biol. 2017;334:99-175. doi: 10.1016/bs.ircmb.2017.03.007. Epub 2017 Apr 21.
7
MicroRNAs in benign and malignant hematopoiesis.微小 RNA 在良性和恶性造血中的作用。
Arch Pathol Lab Med. 2010 Sep;134(9):1276-81. doi: 10.5858/2009-0178-RS.1.
8
The role of miR-150 in normal and malignant hematopoiesis.miR-150 在正常和恶性造血中的作用。
Oncogene. 2014 Jul 24;33(30):3887-93. doi: 10.1038/onc.2013.346. Epub 2013 Aug 19.
9
Potential therapeutic applications of miRNA-based technology in hematological malignancies.基于微小RNA的技术在血液系统恶性肿瘤中的潜在治疗应用。
Curr Pharm Des. 2008;14(21):2040-50. doi: 10.2174/138161208785294627.
10
MicroRNA: Defining a new niche in Leukemia.微小RNA:在白血病中定义一个新的生态位。
Blood Rev. 2017 May;31(3):129-138. doi: 10.1016/j.blre.2016.11.003. Epub 2016 Nov 24.

引用本文的文献

1
miRNA-7145-cuedc2 axis controls hematopoiesis through JAK1/STAT3 signaling pathway.微小RNA-7145-库德西2轴通过JAK1/STAT3信号通路控制造血作用。
Cell Death Discov. 2024 May 2;10(1):209. doi: 10.1038/s41420-024-01977-6.
2
MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.微小RNA:慢性淋巴细胞白血病中潜在的预后和诊疗生物标志物
EJHaem. 2024 Feb 11;5(1):191-205. doi: 10.1002/jha2.849. eCollection 2024 Feb.
3
MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.

本文引用的文献

1
Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients.TLR4和miR-155在冠状动脉血流缓慢及冠状动脉粥样硬化患者外周血单核细胞介导的炎症反应中的作用
J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22232. Epub 2017 Apr 13.
2
Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice.姜黄素的抗炎作用与下调脂多糖处理的巨噬细胞和小鼠中的微小RNA-155有关。
Pharm Biol. 2017 Dec;55(1):1263-1273. doi: 10.1080/13880209.2017.1297838.
3
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.
骨髓和淋巴结中 B 细胞淋巴瘤的 microRNA 表达谱。
Int J Mol Sci. 2023 Oct 11;24(20):15082. doi: 10.3390/ijms242015082.
4
The Role of Non-Coding RNAs in Myelodysplastic Neoplasms.非编码RNA在骨髓增生异常综合征中的作用
Cancers (Basel). 2023 Sep 30;15(19):4810. doi: 10.3390/cancers15194810.
5
Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.微小RNA在血液系统恶性肿瘤和造血干细胞移植中的临床意义
Cancers (Basel). 2023 May 8;15(9):2658. doi: 10.3390/cancers15092658.
6
Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations.近期对微小RNA和长链非编码RNA介导的干细胞群体调控的见解。
3 Biotech. 2022 Oct;12(10):270. doi: 10.1007/s13205-022-03343-8. Epub 2022 Sep 10.
7
DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation.DNA 甲基转移酶-1 在急性髓系白血病中的作用:超越 DNA 甲基化的维持。
Ann Med. 2022 Dec;54(1):2011-2023. doi: 10.1080/07853890.2022.2099578.
8
Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells.多发性骨髓瘤来源的细胞外囊泡通过作用于造血干细胞和祖细胞损害正常造血。
Front Med (Lausanne). 2021 Dec 16;8:793040. doi: 10.3389/fmed.2021.793040. eCollection 2021.
9
MicroRNAs in the Myelodysplastic Syndrome.骨髓增生异常综合征中的微小RNA
Acta Naturae. 2021 Apr-Jun;13(2):4-15. doi: 10.32607/actanaturae.11209.
10
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review.探索用于寡转移前列腺癌特征描述的miRNA特征及其他潜在生物标志物:临床实践背后的生物学挑战。一篇叙述性综述。
Cancers (Basel). 2021 Jun 30;13(13):3278. doi: 10.3390/cancers13133278.
对正常B细胞晚期分化阶段中涉及的微小RNA的鉴定表明,微小RNA靶标ZEB1和TP53发挥着核心作用。
Oncotarget. 2017 Feb 14;8(7):11809-11826. doi: 10.18632/oncotarget.14683.
4
miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-β signaling pathway.微小RNA-155通过转化生长因子-β信号通路调节高糖诱导的心脏纤维化。
Mol Biosyst. 2016 Dec 20;13(1):215-224. doi: 10.1039/c6mb00649c.
5
Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines.γ-疱疹病毒感染的淋巴瘤细胞系中外泌体和细胞内微小RNA的概况
PLoS One. 2016 Sep 9;11(9):e0162574. doi: 10.1371/journal.pone.0162574. eCollection 2016.
6
Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy .LMP1敲低诱导的miR-155使鼻咽癌细胞对放疗敏感。
Oncol Lett. 2016 May;11(5):3451-3456. doi: 10.3892/ol.2016.4400. Epub 2016 Mar 31.
7
miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.miR-21表达可预测弥漫性大B细胞淋巴瘤的预后。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15019-24. eCollection 2015.
8
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies.Myc在血液系统恶性肿瘤中响应HDAC抑制诱导miRNA介导的细胞凋亡。
Cancer Res. 2016 Feb 1;76(3):736-48. doi: 10.1158/0008-5472.CAN-15-1751. Epub 2015 Dec 16.
9
The microRNA-212/132 cluster regulates B cell development by targeting Sox4.微小RNA-212/132簇通过靶向Sox4来调节B细胞发育。
J Exp Med. 2015 Sep 21;212(10):1679-92. doi: 10.1084/jem.20150489. Epub 2015 Sep 14.
10
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.在患有各种类型血液系统肿瘤性疾病的患者中,会释放出血清中表达恶性肿瘤相关标志物的细胞外囊泡水平升高。
Tumour Biol. 2015 Dec;36(12):9739-52. doi: 10.1007/s13277-015-3741-3. Epub 2015 Jul 9.